Forte Group Holdings, Inc. engages in the development and manufacture of alkaline, mineralized, and cannabinoid beverages and supplements for both in-house brands and white-label clients. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-07-02. The firm develops and manufactures a range of alkaline and mineral-enriched beverages and nutraceutical supplements for both its TRACE brand and private-label clients. The company operates through two segments: alkaline and mineralized beverages and supplements and eCommerce. The alkaline and mineralized beverages include the development and manufacturing of the TRACE brand and other beverages and supplements. The eCommerce segment includes direct-to-customer sales of natural health products, including nutraceutical and hemp-based cannabidiol products. The firm owns a pristine natural alkaline spring water aquifer and operates a 40,000-square-foot, Health Canada-and HACCP-certified manufacturing facility near Osoyoos, British Columbia. Its distribution network includes traditional retail and e-commerce channels, delivering wellness-focused products directly to consumers.
Forte Group Holdings Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
TScan Therapeutics Inc 주요 수익원은 T Cell Receptor-engineered T Cell이며, 최신 수익 발표에서 수익은 2,816,000입니다. 지역별로는 United States이 TScan Therapeutics Inc의 주요 시장이며, 수익은 2,816,000입니다.
Forte Group Holdings Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 TScan Therapeutics Inc의 순손실은 $0입니다.